Open AccessEffective combined therapy for pulmonary epithelioid hemangioendothelioma: A case report
Author(s) -
Xiuqin Zhang,
Heng Chen,
Shu Song,
Yan Qin,
Liming Cai,
Fang Zhang
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i10.2009
Subject(s) - medicine , apatinib , epithelioid hemangioendothelioma , chemotherapy , cyclophosphamide , radiology , doxorubicin , gefitinib , surgery , cancer , immunohistochemistry , epidermal growth factor receptor
Pulmonary epithelioid hemangioendothelioma (P-EHE) is a rare disease. Thus far, consensus on a standard treatment for P-EHE has not been established given its low incidence worldwide. Apatinib combined with chemotherapy with doxorubicin/cyclophosphamide has been used as an effective combination treatment for human malignancies. However, the efficacy of this combination has not been reported in P-EHE cases.